SCHEMBL25796607

SCHEMBL25796607

COC(=O)c1nn(C)cc1NP

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.53
KMT2A Q03164 2/20 0.43
GLA P06280 1/20 0.43
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 1/20 0.38
KDM4E B2RXH2 4/20 0.36
NPC1 O15118 2/20 0.36
TP53 P04637 2/20 0.36
RAB9A P51151 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPK1 P28482 2/20 0.35
ALDH1A1 P00352 2/20 0.35
ALOX15 P16050 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 4/20 0.35
THRB P10828 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21960946 0.84 CNR2 (0.55) CNR2KMT2AGLANPSR1L3MBTL1
SCHEMBL17923514 0.80 CNR2 (0.51) CNR2KMT2AGLANPSR1L3MBTL1
SCHEMBL23385487 0.79 KDM4E (0.49) KMT2ANPSR1MEN1KDM4ENPC1
SCHEMBL985062 0.77 KMT2A (0.59) CNR2KMT2AGLAMEN1KDM4E
SCHEMBL4443917 0.77 CNR2 (0.47) CNR2KMT2AGLANPSR1L3MBTL1
SCHEMBL2210341 0.77 CNR2 (0.47) CNR2KMT2AGLANPSR1L3MBTL1
SCHEMBL1881450 0.76 CNR2 (0.54) CNR2KMT2AGLANPSR1L3MBTL1
SCHEMBL22857997 0.75 CNR2 (0.53) CNR2KMT2AGLAL3MBTL1
SCHEMBL19893122 0.75 CNR2 (0.47) CNR2KMT2AGLANPSR1L3MBTL1
SCHEMBL22749175 0.75 CNR2 (0.47) CNR2KMT2AGLAL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691970-B2 Pyrazolopyridinone compounds JANSSEN PHARMACEUTICA NV (BE) 2023-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691970-B2 Pyrazolopyridinone compounds FGFR1, FGFR3, FGFR2 CNR2 2627/4885KMT2A 1583/4885GLA 2900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.